Two-year assessment of the efficacy and safety of sitagliptin in elderly patients with type 2 diabetes: Post hoc analysis of the ASSET-K study

Overview of attention for article published in BMC Endocrine Disorders, July 2015

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (55th percentile)
Good Attention Score compared to outputs of the same age and source (66th percentile)

So far, Altmetric has seen 5 X posts from 5 X users, with an upper bound of 25,870 followers.

Eficacia y seguridad de #sitagliptina en ancianos: análisis post hoc del estudio ASSET-K http://t.co/P4qodj7oo8 #diabetes

BMC Endocrine Disorders: Two-year assessment of the efficacy and safety of sitagliptin in elderly T2D http://t.co/87hUT46jmn

BMC Endocrine Disorders: Two-year assessment of the efficacy and safety of sitagliptin in elderly T2D http://t.co/pblC5Ama8F

BMC Endocrine Disorders: Two-year assessment of the efficacy and safety of sitagliptin in elderly T2D http://t.co/KHhqEO95cZ

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 1 additional X posts.